A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
A High Quality High Content Screening Assay for Intracellular Leishmania Manu De Rycker, University of Dundee, speaking at Screening Europe 2011
High Content Screening for Cytoskeletal Rearrangements María Montoya, Centro Nacional de Investigaciones Cardiovasculares, speaking at Screening Europe 2011
Kinetic Monitoring of Cellular cAMP/cGMP Signalling Reinhard Seifert, Sibion Biosciences, speaking at Screening Europe 2011
From Acquisition to Analysis: Tools to Improve the High Content Screening Workflow for Stem Cell Assays Ben Haworth, Molecular Devices, speaking at Screening Europe 2011.
Development of an Ultra-high Throughput Long Non-coding RNA Screening System Jan Hellemans, speaking at Advances in qPCR 2011
Latent Hit Identification in Primary Screening Data with Compound Set Enrichment Thibault Varin, PostDoctoral Fellow, Novartis, Speaking at Medchem Europe 2011.
State-of-the-Art in Ligand-Based Virtual Screening Jürgen Bajorath, Professor, Department of Life Science Informatics, University of Bonn, speaking at Medchem Europe 2011.
Enhancing Success Rates in Virtual Screening Giulio Rastelli, Associate Professor in Medicinal Chemistry at the University of Modena, speaking at Medchem Europe 2011.